28 August 2020 - There is actually only one Public Summary Document from the May 2020 PBAC meeting.
The Public Summary Document relates to a submission from Terumo seeking a PBS listing of methoxsalen delivered via an integrated, closed system, extracorporeal photopheresis (ECP), for the treatment of patients with erythrodermic stage III-IVa T4 M0 cutaneous T-cell lymphoma who are refractory to one or more systemic treatments.